Filter
472
Filtered Results: 472
Text search:
pyrazinamide
Featured
Recommendations
70
New Publications
131
Language
Document type
No document type
319
Guidelines
78
Manuals
26
Studies & Reports
21
Training Material
12
Strategic & Response Plan
7
Fact sheets
7
Situation Updates
2
Countries / Regions
Western and Central Europe
25
India
25
Nepal
14
Eastern Europe
12
Kenya
11
Argentina
11
Senegal
8
Peru
8
Tanzania
8
Bangladesh
8
Ethiopia
8
South Africa
7
Uganda
7
Malawi
6
Germany
6
Paraguay
6
Indonesia
6
Ukraine
5
Bolivia
5
Zambia
5
Colombia
4
Nigeria
4
Philippines
4
Mozambique
4
Cambodia
4
Brazil
4
Russia
4
Namibia
4
El Salvador
3
Lesotho
3
Ghana
3
Rwanda
3
Latin America and the Carribbean
3
Congo, Democratic Republic of
3
Botswana
3
Ecuador
3
Myanmar / Burma
3
Eswatini/ Swaziland
3
Benin
2
Cameroon
2
Burkina Faso
2
Zimbabwe
2
Haiti
2
Tajikistan
1
Switzerland
1
Gambia
1
Chile
1
Malaysia
1
Asia
1
Venezuela
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Uruguay
1
Romania
1
Central African Republic
1
Chad
1
Libya
1
Bhutan
1
Liberia
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
129
TB
60
Drugs & Medical Equipment
38
Guidelines
34
Studies & Reports
19
Pediatrics
15
Capacity Building
13
Women & Child Health
9
Paediatrics
8
Policies
7
Demograhic Health Surveys DHS
5
Community Health
5
Disease Prevention & Control
5
Bacteriology
4
COVID-19
3
Countries
3
Statistics
3
HIV & STI
3
Clinical Guidelines
2
Communicable Diseases
2
NTDs & Others
2
Communicable Diseases
1
Dental & Eye Care
1
Clinical Training
1
Public Health
1
Under-5 nutrition
1
Child Health
1
Buruli Ulcer
1
Diabetes
1
Dermatology
1
Maternal & Child Health
1
Public Health
1
Vaccine-preventable Diseases
1
Information, Education and Communication (IEC)
1
Quality Control & Assurance
1
Reproductive Health
1
Toolboxes
Drug resistant TB
43
Adults
30
Children
26
Detection & Diagnosis
24
Essential Medicines & Devices Lists
22
Training
18
Prevention & Control
12
Childhood TB
10
General
10
TB/HIV Coinfection
10
Argentina
9
TB & Prisoners
9
Peru
8
Other Countries
8
Research & Access
8
TB
8
Essential Medicines
6
Romania
6
Tuberculosis
6
Germany
6
Clinical Aspects
5
Children & Adolescents
5
IEC Materials
5
Brazil
5
HIV &TB
5
Disease Prevention & Control
5
Nutrition
5
TB & Drug Abuse
4
Moldova
4
Treatment & Prevention
4
Communication & Training
4
South-east Asia Region
4
Kenya
4
Policies & Strategies
3
Vaccines & Immunization
3
Ukraine
3
Laboratory
3
TB & Other Vulnerable Populations
3
Ethiopia
3
Essential List
3
Hospital Readiness/Essential Health Services
3
Colombia
3
El Salvador
3
Falsified & Substandard
3
Malawi
3
Clinical Guidelines
3
Eastern Europe & Central Asia
3
Country specific
2
South Africa
2
Eastern Mediterranean Region
2
Namibia
2
TB
2
Mozambique
2
Country Guidelines
2
Reports
2
Country Specific
2
TB/HIV
2
TB/COVID-19
2
Latin America
2
Ecuador
2
Prices and Patents
2
Model Formulary
2
Pharmacy Practice
2
Policies and guidelines
2
Uganda
2
HIV and coinfection
2
Kazakhstan
2
Western & Central Europe
2
AmR (Region of Americas)
2
Epidemiology
2
Biosafety
1
Azerbaijan
1
Clinical Aspects, Treatment & Prevention
1
Policies & Strategies
1
Clinical Guidelines
1
Pediatrics
1
Opportunistic Infections
1
Prevention Guidelines
1
National Policies
1
Social Worker
1
Eastern Europe
1
HIV
1
Global
1
People who injecting Drugs
1
Rwanda
1
Prophylaxis
1
Vaccination
1
Health & Refugee
1
Georgia
1
Drug resistance
1
Workplace
1
Belarus
1
HIV / AIDS
1
Medical professionals
1
Russia
1
DR Congo
1
Clinical Guidelines
1
Country specific documents
1
Essential Medicines & Medical Devices
1
Community Health Workers CHW
1
Advocacy & Communication
1
Chile
1
Rational use of Medicine
1
Health Worker
1
General
1
Botswana
1
Co-Morbidities (except TB)
1
Neurological Disorders
1
Ghana
1
Community Worker
1
TB/HIV Global
1
Lesotho
1
Latin America & the Carribean
1
Clinical Guidelines
1
Nigeria
1
Tajikistan
1
Antiretroviral Treatment ART
1
Preparedness & Prevention
1
Case Definitions
1
Prisoners
1
Meningitis & Encephalitis
1
Volunteers
1
SEAR (South-east Asia Region)
1
Se estima que unos 10 millones de personas contrajeron tuberculosis (TB) en el 2019 y que a unos 3 millones de ellas no se les diagnosticó ni se les notificó la enfermedad. Con el propósito de poner fin a la epidemia mundial de la tuberculosis para el 2030, sigue siendo necesario ampliar la capac...
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients with rifampicin-resistant and multi-drug resistant T...
100 test methods for 100 active pharmaceutical ingredients
For existing Minilab projects that want to replace old manuals or initiatives that want to start new projects, the new "Minilab Edition 2020" can be obtained at the preferential price of 50 € from our logistic partner Technologie Transfer...
100 méthodes d'essai pour 100 principes pharmaceutiques actifs
Pour les projets Minilab existants qui souhaitent remplacer les anciens manuels ou les initiatives qui veulent lancer de nouveaux projets, la nouvelle "Minilab Edition 2020" peut être obtenue au prix préférentiel de 50 € auprès d...
Downloaded from https://aidsinfo.nih.gov/guidelines on 11/27/2019
Visit the AIDSinfo website to access the most up-to-date guideline.
Register for e-mail notification of guideline updates at https://aidsinfo.nih.gov/e-news.
Accessed: 08.10.2019
Based on the National Guidelines for the Management of Tuberculosis in Children 2013, Department of Health, South Africa.
INT J TUBERC LUNG DIS 22(2):197–205 http://dx.doi.org/10.5588/ijtld.17.0245
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis treatment outcomes in Burkina Faso. The current study investigated the factors associated with tuberculosis treatment failure in the central east ...
15. Euro Surveill. 2017;22(47):pii=17-00103
The modules (1-12) are based on materials originally developed by FIND, KNCV and Cepheid, and are in PowerPoint format for country customization. Depending on the audience, modules may be selected and adapted according to need (e.g. basic users, supervisors, clinicians). Topics covered include: Over...
Accessed November 2017
Série de bulletins techniques
Tuberculose et co-infection par le VIH | 1 - 3
Accessed November 2017
Lessons from the STEP-TB Project.
Accessed November 2017.
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Uptsate 2017
WHO recommendations on child health: Guidelines approved by the WHO Guidelines Review Committee
recommended
Updated May 2017
This document is meant to respond to the questions:
■ What health interventions should the child receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
This document is meant to respond to the questions:
■ What health interventions should the child receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
